{
  "directed": true,
  "graph": {
    "annotation_list": {
      "PublicationStatus": [
        "Preprint"
      ],
      "PublicationType": [
        "Research"
      ],
      "Section": [
        "Conclusion",
        "Results"
      ]
    },
    "annotation_pattern": {
      "BioAssay": ".*"
    },
    "annotation_url": {},
    "document_metadata": {
      "authors": "Priya S",
      "contact": "priya@causalitybiomodels.com",
      "copyright": "Copyright © 2020 Fraunhofer Institute SCAI, All rights reserved",
      "description": "COVID Knowledge Curation project",
      "licenses": "Private Ownership to Fraunhofer Institute SCAI",
      "name": "Omotuyi_et.al_2020.bel",
      "version": "2.0.0"
    },
    "namespace_pattern": {
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "COVID": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-covid19/ncbi-covid19-20200326.belns",
      "GO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/go/go-20180109.belns",
      "HGNC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hgnc/hgnc-20190708.belns"
    },
    "path": "Omotuyi_et.al_2020.bel",
    "pybel_version": "0.14.6"
  },
  "links": [
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "When ACE-2 and RBD were tested for UBR binding separately, a nearly similar result (Fig. 2B, i&ii) was obtained strongly indicating that UBR binding is predominantly driven by ACE-2. The estimated energy of binding supports this conclusion as RBD/UBR, ACE-2/UBR and RBD/ACE-2/UBR binding energies were estimated as -45.93 ± 2.89, -50.19 ± 4.32 and -72.16 ± 4.09 kcal/mol (Table 1.0). By implication, UBR has the highest affinity for RBD/ACE-2 complex but can also bind to unoccupied receptor.",
      "key": "fc3fa2a623cc1339ad31dc3936e9f494",
      "line": 43,
      "relation": "decreases",
      "source": 0,
      "target": 4
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "When ACE-2 and RBD were tested for UBR binding separately, a nearly similar result (Fig. 2B, i&ii) was obtained strongly indicating that UBR binding is predominantly driven by ACE-2. The estimated energy of binding supports this conclusion as RBD/UBR, ACE-2/UBR and RBD/ACE-2/UBR binding energies were estimated as -45.93 ± 2.89, -50.19 ± 4.32 and -72.16 ± 4.09 kcal/mol (Table 1.0). By implication, UBR has the highest affinity for RBD/ACE-2 complex but can also bind to unoccupied receptor.",
      "key": "e4868126e119520e73a81be648a1df93",
      "line": 44,
      "relation": "decreases",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Conclusion": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "The ability of ubrogepant to rupture the interaction at the RBD/ACE-2 interface residues of SARS-CoV-2 RBD/ACE-2 complex may result in loss of protein function with direct implication on oligomerization formation in RBD and loss of function in ACE-2 thus, making binding, cellular receptor recognition impossible.",
      "key": "09d631247db4a5051b03e0042f9096b2",
      "line": 55,
      "relation": "decreases",
      "source": 0,
      "target": 5
    },
    {
      "annotations": {
        "BioAssay": {
          "molecular docking": true
        },
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Results": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "When ACE-2 and RBD were tested for UBR binding separately, a nearly similar result (Fig. 2B, i&ii) was obtained strongly indicating that UBR binding is predominantly driven by ACE-2. The estimated energy of binding supports this conclusion as RBD/UBR, ACE-2/UBR and RBD/ACE-2/UBR binding energies were estimated as -45.93 ± 2.89, -50.19 ± 4.32 and -72.16 ± 4.09 kcal/mol (Table 1.0). By implication, UBR has the highest affinity for RBD/ACE-2 complex but can also bind to unoccupied receptor.",
      "key": "6fe407a920500b3c7dc2a02befc44b24",
      "line": 45,
      "relation": "decreases",
      "source": 0,
      "target": 2
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Conclusion": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "The ability of ubrogepant to rupture the interaction at the RBD/ACE-2 interface residues of SARS-CoV-2 RBD/ACE-2 complex may result in loss of protein function with direct implication on oligomerization formation in RBD and loss of function in ACE-2 thus, making binding, cellular receptor recognition impossible.",
      "key": "996787168a74195535acd5006805a3af",
      "line": 52,
      "relation": "decreases",
      "source": 0,
      "target": 2
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Conclusion": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "The ability of ubrogepant to rupture the interaction at the RBD/ACE-2 interface residues of SARS-CoV-2 RBD/ACE-2 complex may result in loss of protein function with direct implication on oligomerization formation in RBD and loss of function in ACE-2 thus, making binding, cellular receptor recognition impossible.",
      "key": "83bb7a41882af9968d380affa57f4e0c",
      "line": 54,
      "relation": "decreases",
      "source": 0,
      "target": 1
    },
    {
      "key": "65c4c4fe1afdcb0cfe56c970dad369ae",
      "relation": "partOf",
      "source": 4,
      "target": 2
    },
    {
      "annotations": {
        "PublicationStatus": {
          "Preprint": true
        },
        "PublicationType": {
          "Research": true
        },
        "Section": {
          "Conclusion": true
        }
      },
      "citation": {
        "db": "DOI",
        "db_id": "10.20944/preprints202003.0466.v1"
      },
      "evidence": "The ability of ubrogepant to rupture the interaction at the RBD/ACE-2 interface residues of SARS-CoV-2 RBD/ACE-2 complex may result in loss of protein function with direct implication on oligomerization formation in RBD and loss of function in ACE-2 thus, making binding, cellular receptor recognition impossible.",
      "key": "e2af5aa61ff8aab111389c2220968658",
      "line": 53,
      "relation": "increases",
      "source": 4,
      "target": 1
    },
    {
      "key": "0393182d9e39a5e7e67a548c82f9a05f",
      "relation": "hasVariant",
      "source": 3,
      "target": 4
    },
    {
      "key": "fe9e8a6933abf85d564a0ac563f389a1",
      "relation": "partOf",
      "source": 5,
      "target": 2
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(PUBCHEM:68748835)",
      "concept": {
        "name": "68748835",
        "namespace": "PUBCHEM"
      },
      "function": "Abundance",
      "id": "d8d6b3f92cf943699b0ba6881636817f"
    },
    {
      "bel": "bp(GO:\"protein oligomerization\")",
      "concept": {
        "name": "protein oligomerization",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "e3d42e0481ad62c21beed29c1be81d5b"
    },
    {
      "bel": "complex(p(COVID:S, frag(\"319_541\")), p(HGNC:ACE2))",
      "function": "Complex",
      "id": "e4bad8c5027a87c3dc120bb48c1e6783",
      "members": [
        {
          "bel": "p(COVID:S, frag(\"319_541\"))",
          "concept": {
            "name": "S",
            "namespace": "COVID"
          },
          "function": "Protein",
          "id": "b846d54bc73166bf103413cf895b1acd",
          "variants": [
            {
              "kind": "frag",
              "start": 319,
              "stop": 541
            }
          ]
        },
        {
          "bel": "p(HGNC:ACE2)",
          "concept": {
            "name": "ACE2",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
        }
      ]
    },
    {
      "bel": "p(COVID:S)",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "8d090715298e11996081058536798c19"
    },
    {
      "bel": "p(COVID:S, frag(\"319_541\"))",
      "concept": {
        "name": "S",
        "namespace": "COVID"
      },
      "function": "Protein",
      "id": "b846d54bc73166bf103413cf895b1acd",
      "variants": [
        {
          "kind": "frag",
          "start": 319,
          "stop": 541
        }
      ]
    },
    {
      "bel": "p(HGNC:ACE2)",
      "concept": {
        "name": "ACE2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bb9a231a2c68ff8f3bad2adad9ed6a94"
    }
  ]
}